Ads

 

Ads

 

Ads

 

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biopharmaceutical Companies 2024
Metatag Abstract
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.
  1. Aimmune Therapeutics

    World Rank (Jan-05-2024)
    4,918
    World Rank (Jul-30-2023)
    4,918
    World Rank (Dec-25-2022)
    4,918
    World Rank (Jan-07-2022)
    4,918
    Headquarters Country
    Company Profile
    Aimmune Therapeutics is a biopharmaceutical company developing and bringing new treatments to people with potentially life-threatening food allergies. Headquarters is in USA.
  2. Neumora Therapeutics Inc.

    World Rank (Jan-05-2024)
    4,950
    Market Cap (Jan-05-2024)
    2.503 Billion USD
    World Rank (Jul-30-2023)
    6,835
    Market Cap (Jul-30-2023)
    1.515 Billion USD
    Headquarters Country
    Company Profile

    Neumora Therapeutics Inc. is a biopharmaceutical company currently working on Neuroscience Drug Development to Pioneer a New Era of Medicines for Brain Diseases. Headquarters is in USA.

  3. Provention Bio

    World Rank (Jan-05-2024)
    5,145
    World Rank (Jul-30-2023)
    5,145
    Market Cap (Jul-30-2023)
    2.370 Billion USD
    World Rank (Dec-25-2022)
    9,337
    Market Cap (Dec-25-2022)
    0.839 Billion USD
    World Rank (Jan-07-2022)
    16,071
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -99 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile

    Provention Bio is a Clinical Stage Biopharmaceutical company. The headquarters is in USA.

  4. Arvinas

    World Rank (Jan-05-2024)
    5,263
    Market Cap (Jan-05-2024)
    2.279 Billion USD
    World Rank (Jul-30-2023)
    7,862
    Market Cap (Jul-30-2023)
    1.197 Billion USD
    World Rank (Dec-25-2022)
    5,940
    Market Cap (Dec-25-2022)
    1.741 Billion USD
    World Rank (Jan-07-2022)
    4,198
    Market Cap (Jan-07-2022)
    3.65 Billion USD
    Annual Revenue in USD
    131 Million USD
    Annual Operating Income in USD
    -263 Million USD
    Annual Net Income in USD
    -282 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Arvinas is a Clinical Stage Biopharmaceutical company. It is focused on developing new therapeutics for cancers and other difficult to treat diseases and on high value targets in cancer including the androgen and estrogen receptors associated with prostate and breast cancers, respectively. The headquarters is in USA.

  5. Dice Therapeutics Inc.

    World Rank (Jan-05-2024)
    5,326
    World Rank (Jul-30-2023)
    5,326
    Market Cap (Jul-30-2023)
    2.244 Billion USD
    World Rank (Dec-25-2022)
    6,517
    Market Cap (Dec-25-2022)
    1.514 Billion USD
    World Rank (Jan-07-2022)
    10,632
    Market Cap (Jan-07-2022)
    0.81 Billion USD
    Headquarters Country
    Company Profile

    DICE THERAPEUTICS is a Biopharmaceutical company with headquarters is in USA.

    DICE THERAPEUTICS is developing transformative medicines for autoimmune and inflammatory diseases.

    ELI LILLY COMPANY acquired DICE THERAPEUTICS, INC for 2.4 billion USD.

  6. Chemocentryx

    World Rank (Jan-05-2024)
    5,410
    World Rank (Jul-30-2023)
    5,410
    World Rank (Dec-25-2022)
    5,410
    World Rank (Jan-07-2022)
    5,410
    Market Cap (Jan-07-2022)
    2.56 Billion USD
    Annual Revenue in USD
    32 Million USD
    Annual Net Income in USD
    -131 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    ChemoCentryx is a Biopharmaceutical company. It portfolio of therapeutics in areas such as orphan and rare diseases, chronic kidney disease, immuno oncology and inflammatory and autoimmune diseases. The headquarters is in USA.
  7. PTC Therapeutics Inc.

    World Rank (Jan-05-2024)
    5,486
    Market Cap (Jan-05-2024)
    2.120 Billion USD
    World Rank (Jul-30-2023)
    4,320
    Market Cap (Jul-30-2023)
    3.037 Billion USD
    World Rank (Dec-25-2022)
    4,471
    Market Cap (Dec-25-2022)
    2.661 Billion USD
    World Rank (Jan-07-2022)
    5,237
    Market Cap (Jan-07-2022)
    2.69 Billion USD
    Annual Revenue in USD
    698 Million USD
    Annual Operating Income in USD
    -439 Million USD
    Annual Net Income in USD
    -559 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    PTC Therapeutics is a Commercial and Diversified Biopharmaceutical company. It operates offices and research labs in more than 20 countries and occupy a business footprint in more than 50 countries around the world. It is a having 2,20,000 square feet in Hopewell, New Jersey. The headquarters is in USA.

  8. Dynavax Technologies Corporation

    World Rank (Jan-05-2024)
    5,790
    Market Cap (Jan-05-2024)
    1.936 Billion USD
    World Rank (Jul-30-2023)
    6,079
    Market Cap (Jul-30-2023)
    1.826 Billion USD
    World Rank (Dec-25-2022)
    6,923
    Market Cap (Dec-25-2022)
    1.377 Billion USD
    World Rank (Jan-07-2022)
    7,127
    Market Cap (Jan-07-2022)
    1.62 Billion USD
    Annual Revenue in USD
    722 Million USD
    Annual Operating Income in USD
    282 Million USD
    Annual Net Income in USD
    293 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Dynavax Technologies Corporation is a Fully Integrated Biopharmaceutical company focused on leveraging the power of the body's innate and adaptive immune responses through Toll like Receptor (TLR) stimulation. The headquarters is in USA.
    Facts About Company
    The company annual revenue is 46.55 million USD and 249 employees as on 2020.
  9. Harmony Biosciences Holdings Inc.

    World Rank (Jan-05-2024)
    5,928
    Market Cap (Jan-05-2024)
    1.871 Billion USD
    World Rank (Jul-30-2023)
    5,534
    Market Cap (Jul-30-2023)
    2.111 Billion USD
    World Rank (Dec-25-2022)
    3,759
    Market Cap (Dec-25-2022)
    3.363 Billion USD
    World Rank (Jan-07-2022)
    5,877
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    437 Million USD
    Annual Operating Income in USD
    120 Million USD
    Annual Net Income in USD
    181 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Harmony Biosciences Holdings is a Pharmaceutical company. It focuses on disorders of sleep and wakefulness and currently working to advance the understanding of narcolepsy and provide information and resources to people who live with and healthcare professionals who treat, this chronic, debilitating neurologic disorder. The headquarters is in USA.

    Facts About Company

    The company annual revenue was 437 million USD and net income was 181 million USD as on 2022.

  10. Viking Therapeutics

    World Rank (Jan-05-2024)
    5,954
    Market Cap (Jan-05-2024)
    1.859 Billion USD
    World Rank (Jul-30-2023)
    7,050
    Market Cap (Jul-30-2023)
    1.442 Billion USD
    World Rank (Dec-25-2022)
    10,811
    Market Cap (Dec-25-2022)
    0.648 Billion USD
    World Rank (Jan-07-2022)
    16,059
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -70 Million USD
    Annual Net Income in USD
    -69 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Viking Therapeutics is a Clinical Stage Biopharmaceutical company. It is focused on the development of novel, orally available, first in class or best in class therapies for the treatment of metabolic and endocrine disorders. The company annual revenue is 7.3 million USD and 15 employees as 2019. The headquarters is in USA.

Share

Ads